Stoke Therapeutics STOK SEC Filings

NASDAQ STOK
$29.54 -0.45 (-1.50%)
As of: Sep 4, 2026 · 12:50 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Stoke Therapeutics, Inc. (STOK) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index